Abstract
An asynchronous merging zones was proposed with simultaneous introduction of the sample and of the modifier reagent, ascorbic acid in the studied case, for sequential determination of Fe(II) and Fe(III) in pharmaceutical products. The sample and reagent attained a merging point at different times owing to the use of a delay reactor in the reagent channel. By inserting a large sample and controlling the dispersion in the flow system, Fe(II) and Fe(III) were sequentially measured in the front and in the rear of the sample zone, respectively. The results obtained for Fe redox speciation in pharmaceutical products are in agreement at a 95% confidence level with those obtained with a manual spectrophotometric procedure. The analytical frequency with the proposed flow analysis system was 54 samples h −1, i.e. 108 determinations h −1.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
